Chairs: Filip K. Knop (DNK), Ania Jastreboff (USA) 09:00 – 09:10 Welcome and introductions Chairs 09:10 – 09:20 100 years in diabetes history Stephen Gough
Chair: Emma Wilmot (UK) 10:45 – 10:50 Welcome and introduction Emma Wilmot (UK) 10:50 – 11:15 Models of care: The burden of diabetes and enabling
11:30 – 11:35 Welcome and Introduction 11:35 – 11:45 If You Don’t Seek, You Won’t Find: Early Recognition, Screening, and Diagnosis of CKD in Patients
12:00 – 12:15 Welcome and Introduction to Tirzepatide Jennifer Green (USA) 12:15 – 12:30 What Do We Know About How Tirzepatide Compares to Semaglutide 1.0mg?
Chairs: Lutz Heinemann (GER), Thomas Haak (GER) 13:00 – 13:05 Welcome and introduction All chairs 13:05 – 13:10 Sinocare Meditech: committed to innovation in CGM
Chair: Melanie Davies (UK) 13:30 – 13:35 Welcome and introduction Lee Kaplan (USA) 13:35 – 13:50 Treating the disease of obesity: will emerging therapies rise
Chair: Michael Roden (GER) 12:00 – 12:05 Introduction Michael Roden (GER) 12:05 – 12:20 NASH: a growing unmet therapeutic need Jörn Schattenberg (GER) 12:20 –
Chair: Stephan Jacob (GER) 13:30 – 13:35 Chair welcome and introductions Stephan Jacob (GER) 13:35 – 13:45 Charting the ripple effect: Redefining care with SGLT2
Chair: Bernhard Kulzer (GER) 13:30 – 13:40 Leading the Way: The German Perspective Bernhard Kulzer (GER) 13:40 – 14:00 Leading the Way with Clinical Outcomes –
Chair: Emma Wilmot (UK) 14:30 – 14:45 The Foundational Importance of Sensor-Based CGM in the Diabetes Specialist Setting: Identifying New Glycemic Metric “Destinations” Beyond HbA1c Emma
